Various approaches to leveraging the immune system to overcome tumor evasion are revolutionizing cancer treatment. These immuno-oncology (IO) treatments have the potential to generate long-term survival, but despite their success in clinical trials, numerous challenges remain with the use of IO therapeutics. To address these Issues, Frost & Sullivan recently invited academic and industry leaders in the field to participate in a thought leadership forum called our Virtual Think Tank series. Read more about the participants and highlights of their discussions on the topic in this bulletin.
View Bulletin